Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Profile

Christian Young

Concepts (308)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Carcinoma, Squamous Cell
11
2026
644
2.040
 Why?
Head and Neck Neoplasms
10
2026
562
1.920
 Why?
Mammary Neoplasms, Experimental
5
2025
62
1.540
 Why?
Class I Phosphatidylinositol 3-Kinases
6
2025
108
1.380
 Why?
Phosphatidylinositol 3-Kinases
9
2022
380
1.110
 Why?
Keratin-15
2
2025
16
1.080
 Why?
Receptor, ErbB-3
7
2017
48
1.040
 Why?
Mouth Neoplasms
3
2023
90
1.010
 Why?
Breast Neoplasms
12
2017
2373
0.940
 Why?
Smad7 Protein
6
2026
20
0.840
 Why?
Cell Line, Tumor
22
2026
3537
0.840
 Why?
Transforming Growth Factor beta
8
2026
475
0.740
 Why?
Myeloid-Derived Suppressor Cells
1
2023
76
0.740
 Why?
Tumor Suppressor Protein p53
1
2025
536
0.680
 Why?
Mammary Glands, Animal
5
2015
128
0.670
 Why?
Precancerous Conditions
1
2022
166
0.640
 Why?
Proto-Oncogene Proteins c-akt
9
2017
436
0.610
 Why?
Signal Transduction
18
2026
5202
0.580
 Why?
ErbB Receptors
4
2022
635
0.540
 Why?
Mammary Neoplasms, Animal
3
2015
34
0.520
 Why?
Mice
30
2026
18338
0.470
 Why?
Mice, Nude
11
2020
678
0.470
 Why?
Paracrine Communication
1
2015
67
0.430
 Why?
Wound Healing
3
2026
355
0.420
 Why?
Tumor Microenvironment
7
2026
737
0.420
 Why?
Extracellular Signal-Regulated MAP Kinases
1
2015
174
0.420
 Why?
Animals
38
2026
38141
0.410
 Why?
Protein Kinase Inhibitors
3
2017
980
0.380
 Why?
Phosphatidylinositol 3-Kinase
2
2023
24
0.380
 Why?
Disease Models, Animal
9
2025
4559
0.350
 Why?
Glucose Transporter Type 1
1
2011
49
0.340
 Why?
Radiotherapy, Intensity-Modulated
2
2025
142
0.330
 Why?
B7-H1 Antigen
2
2024
243
0.330
 Why?
Stomatitis
2
2021
15
0.320
 Why?
Mucositis
2
2021
20
0.310
 Why?
Cell Proliferation
8
2020
2499
0.310
 Why?
Mice, Transgenic
11
2025
2189
0.310
 Why?
Smad4 Protein
2
2020
33
0.300
 Why?
Apoptosis
4
2020
2411
0.300
 Why?
Keratinocytes
4
2026
250
0.290
 Why?
Up-Regulation
3
2024
848
0.280
 Why?
Fats
1
2008
14
0.270
 Why?
Mutation
3
2015
4093
0.270
 Why?
Radiation Injuries, Experimental
2
2025
20
0.260
 Why?
Neoplastic Stem Cells
2
2022
409
0.250
 Why?
Drug Resistance, Neoplasm
7
2017
881
0.250
 Why?
Reactive Oxygen Species
1
2009
602
0.250
 Why?
Glucose
2
2011
1039
0.240
 Why?
Integrin beta1
1
2026
33
0.240
 Why?
rac1 GTP-Binding Protein
2
2017
56
0.240
 Why?
Xenograft Model Antitumor Assays
6
2020
929
0.230
 Why?
Tumor Escape
1
2026
50
0.230
 Why?
Genes, p53
2
2020
67
0.230
 Why?
Metaplasia
1
2025
57
0.230
 Why?
Radiodermatitis
1
2025
11
0.230
 Why?
Epidermis
1
2026
157
0.220
 Why?
Female
30
2026
78763
0.220
 Why?
Lung Neoplasms
4
2026
2664
0.220
 Why?
Cell Plasticity
1
2025
37
0.220
 Why?
Diabetes Mellitus, Experimental
1
2026
185
0.210
 Why?
Cachexia
1
2025
74
0.210
 Why?
Antineoplastic Combined Chemotherapy Protocols
4
2020
1965
0.210
 Why?
Carcinogenesis
2
2023
227
0.200
 Why?
Phosphatidylinositols
1
2023
57
0.200
 Why?
Dermatitis
1
2023
20
0.200
 Why?
Receptors, Interleukin
1
2023
43
0.190
 Why?
Carcinogens
1
2023
123
0.190
 Why?
Phosphoprotein Phosphatases
1
2002
65
0.190
 Why?
Humans
36
2026
145491
0.180
 Why?
Phosphorylation
6
2015
1707
0.180
 Why?
Glycerol
1
2002
90
0.180
 Why?
Mechanistic Target of Rapamycin Complex 2
3
2017
62
0.180
 Why?
Antineoplastic Agents
4
2017
2207
0.180
 Why?
Immunologic Memory
1
2024
368
0.180
 Why?
Laminin
1
2022
71
0.180
 Why?
Psoriasis
1
2023
115
0.180
 Why?
Receptors, Fibroblast Growth Factor
1
2022
70
0.180
 Why?
Biological Products
1
2025
258
0.170
 Why?
Neoplasms, Experimental
2
2020
168
0.170
 Why?
Gene Expression Regulation, Neoplastic
5
2018
1439
0.160
 Why?
Cancer-Associated Fibroblasts
1
2020
23
0.160
 Why?
Receptor, Fibroblast Growth Factor, Type 1
2
2017
58
0.160
 Why?
Radiation Injuries
1
2021
149
0.160
 Why?
Hyaluronan Receptors
1
2020
105
0.160
 Why?
Tumor Burden
3
2018
324
0.140
 Why?
Cell Movement
3
2018
961
0.140
 Why?
Receptor, EphB3
1
2018
4
0.140
 Why?
CD8-Positive T-Lymphocytes
1
2024
917
0.140
 Why?
Estradiol
2
2013
507
0.140
 Why?
Poly(ADP-ribose) Polymerase Inhibitors
1
2020
132
0.140
 Why?
Estrogen Receptor Modulators
2
2017
14
0.130
 Why?
Multiprotein Complexes
2
2016
172
0.130
 Why?
Protein Binding
2
2015
2250
0.130
 Why?
Morpholines
1
2018
129
0.130
 Why?
Aminopyridines
1
2018
129
0.130
 Why?
Smokers
1
2018
137
0.130
 Why?
Mice, Inbred C57BL
6
2026
5989
0.130
 Why?
Immunoblotting
2
2011
294
0.130
 Why?
Disease-Free Survival
2
2015
771
0.120
 Why?
Neoplasm Transplantation
2
2014
246
0.120
 Why?
Estrogen Receptor alpha
1
2017
151
0.120
 Why?
Quinazolines
2
2017
266
0.120
 Why?
Down-Regulation
2
2015
616
0.110
 Why?
TOR Serine-Threonine Kinases
2
2016
452
0.110
 Why?
Extracellular Matrix
2
2022
562
0.110
 Why?
Hyperplasia
2
2013
177
0.110
 Why?
Amphiregulin
1
2015
27
0.110
 Why?
Protein Kinase C-alpha
1
2015
37
0.110
 Why?
Neuropeptides
1
2015
75
0.110
 Why?
Carrier Proteins
2
2016
733
0.110
 Why?
Cell Adhesion
2
2022
452
0.110
 Why?
Antibodies, Neutralizing
1
2017
342
0.110
 Why?
Epidermal Growth Factor
1
2015
161
0.110
 Why?
Bone Morphogenetic Proteins
1
2015
142
0.110
 Why?
Receptors, Estrogen
1
2017
400
0.110
 Why?
Morphogenesis
1
2015
172
0.100
 Why?
Neoplasm Metastasis
3
2026
691
0.100
 Why?
Gene Expression
3
2014
1478
0.100
 Why?
Carcinoma, Non-Small-Cell Lung
1
2023
1188
0.100
 Why?
Quinolines
1
2015
193
0.100
 Why?
Genes, erbB-2
1
2013
32
0.100
 Why?
Transcriptome
3
2018
1038
0.100
 Why?
Skin
3
2025
766
0.100
 Why?
Chromatography, Liquid
1
2015
445
0.100
 Why?
Autophagy
1
2015
288
0.100
 Why?
Receptors, Calcitriol
2
2010
55
0.100
 Why?
Immunotherapy
1
2018
667
0.100
 Why?
Cell Transformation, Neoplastic
2
2012
337
0.090
 Why?
Heterografts
3
2018
143
0.090
 Why?
Mammary Tumor Virus, Mouse
2
2011
42
0.090
 Why?
Rapamycin-Insensitive Companion of mTOR Protein
3
2017
27
0.090
 Why?
Immunohistochemistry
2
2018
1710
0.090
 Why?
Dogs
2
2025
438
0.090
 Why?
Cell Line
3
2015
2823
0.090
 Why?
Antineoplastic Agents, Hormonal
1
2013
192
0.090
 Why?
Neoplasm Proteins
1
2015
441
0.090
 Why?
NF-kappa B
2
2026
660
0.090
 Why?
Tandem Mass Spectrometry
1
2015
566
0.090
 Why?
Gene Amplification
3
2017
120
0.090
 Why?
Inflammation
2
2023
2883
0.080
 Why?
Macrophages
1
2019
1509
0.080
 Why?
Pyrazoles
1
2015
517
0.080
 Why?
Skin Neoplasms
1
2018
850
0.080
 Why?
Mutation, Missense
1
2013
338
0.080
 Why?
Mice, Inbred BALB C
3
2023
1261
0.080
 Why?
Alkylating Agents
1
2010
24
0.080
 Why?
T-Lymphocytes
1
2019
1996
0.080
 Why?
Transcription, Genetic
1
2017
1468
0.080
 Why?
Triple Negative Breast Neoplasms
1
2013
218
0.080
 Why?
Calcitriol
1
2010
57
0.080
 Why?
Tumor Cells, Cultured
3
2020
883
0.080
 Why?
BRCA1 Protein
1
2010
82
0.070
 Why?
Neoplasm Staging
3
2018
1468
0.070
 Why?
Ovarian Neoplasms
1
2015
595
0.070
 Why?
Cetuximab
2
2020
111
0.070
 Why?
Phthalazines
2
2020
63
0.070
 Why?
Prognosis
4
2020
4323
0.070
 Why?
Polymerase Chain Reaction
1
2011
1049
0.070
 Why?
Proteomics
1
2015
1191
0.070
 Why?
Male
7
2026
72817
0.070
 Why?
L-Lactate Dehydrogenase
1
2008
113
0.070
 Why?
Cell Death
1
2009
383
0.070
 Why?
Insulin-Like Growth Factor I
1
2010
317
0.070
 Why?
Calcifediol
1
2007
31
0.060
 Why?
Vitamin D
1
2010
403
0.060
 Why?
Mitogen-Activated Protein Kinases
2
2011
287
0.060
 Why?
Enzyme Activation
1
2008
762
0.060
 Why?
Oxidative Phosphorylation
1
2008
209
0.060
 Why?
Gene Expression Profiling
1
2013
1769
0.060
 Why?
Carcinoma
1
2008
224
0.060
 Why?
Models, Biological
2
2018
1815
0.060
 Why?
Piperazines
2
2020
378
0.060
 Why?
MAP Kinase Signaling System
2
2011
306
0.060
 Why?
Kidney Neoplasms
1
2010
416
0.060
 Why?
Cell Survival
3
2015
1094
0.060
 Why?
Antibodies, Monoclonal
1
2013
1511
0.060
 Why?
Molecular Targeted Therapy
2
2020
439
0.060
 Why?
Phenotype
3
2023
3157
0.060
 Why?
Glycolysis
1
2008
342
0.060
 Why?
Blotting, Western
3
2016
1162
0.060
 Why?
Magnetic Resonance Spectroscopy
1
2008
625
0.060
 Why?
SKP Cullin F-Box Protein Ligases
1
2025
15
0.060
 Why?
Tripartite Motif Proteins
1
2025
39
0.060
 Why?
Administration, Cutaneous
1
2025
126
0.060
 Why?
Kaplan-Meier Estimate
2
2018
974
0.050
 Why?
Muscular Atrophy
1
2025
87
0.050
 Why?
Lipid Metabolism
1
2008
529
0.050
 Why?
Fluorescent Antibody Technique
2
2018
364
0.050
 Why?
Muscle Fibers, Skeletal
1
2025
214
0.050
 Why?
MCF-7 Cells
2
2014
132
0.050
 Why?
Ubiquitin-Protein Ligases
1
2025
191
0.050
 Why?
Muscle Proteins
1
2025
242
0.050
 Why?
Swine
1
2026
833
0.050
 Why?
Histocompatibility Antigens Class I
1
2024
203
0.050
 Why?
Phosphothreonine
1
2002
6
0.050
 Why?
Nitric Oxide Synthase Type II
1
2023
161
0.050
 Why?
Protein Phosphatase 2C
1
2002
15
0.050
 Why?
Osmosis
1
2002
22
0.050
 Why?
Nuclear Proteins
1
2008
743
0.050
 Why?
Glutathione Transferase
1
2002
96
0.050
 Why?
Protein Transport
2
2017
438
0.050
 Why?
Myeloid Cells
1
2023
146
0.050
 Why?
Cell Cycle Proteins
2
2020
631
0.040
 Why?
Catalytic Domain
1
2002
235
0.040
 Why?
Gene Products, tat
1
2021
22
0.040
 Why?
Luminescent Proteins
1
2002
186
0.040
 Why?
Plasmids
1
2002
375
0.040
 Why?
Biomarkers, Tumor
2
2019
1321
0.040
 Why?
Microscopy, Fluorescence
1
2002
407
0.040
 Why?
Green Fluorescent Proteins
1
2002
407
0.040
 Why?
Mitochondria
1
2008
990
0.040
 Why?
Epithelium
2
2012
310
0.040
 Why?
Zinc Finger E-box-Binding Homeobox 1
1
2020
21
0.040
 Why?
Disease Progression
2
2020
2862
0.040
 Why?
Protein Structure, Tertiary
1
2002
850
0.040
 Why?
Feedback, Physiological
1
2020
81
0.040
 Why?
Neutrophils
1
2026
1124
0.040
 Why?
SOXB1 Transcription Factors
1
2020
67
0.040
 Why?
Prostatic Neoplasms
1
2007
978
0.040
 Why?
Recombinant Fusion Proteins
1
2002
667
0.040
 Why?
Epithelial Cells
2
2019
1112
0.040
 Why?
Transcription Factors
1
2008
1733
0.040
 Why?
Temperature
1
2002
681
0.040
 Why?
Clodronic Acid
1
2019
19
0.040
 Why?
Lymphocytes, Tumor-Infiltrating
1
2020
153
0.040
 Why?
Kinetics
1
2002
1605
0.040
 Why?
Genes, Tumor Suppressor
1
2019
85
0.040
 Why?
Saccharomyces cerevisiae Proteins
1
2002
419
0.040
 Why?
RNA, Neoplasm
1
2018
83
0.040
 Why?
Mice, Inbred NOD
1
2020
613
0.030
 Why?
Guinea Pigs
1
2018
160
0.030
 Why?
Nitric Oxide
1
2023
894
0.030
 Why?
Radiotherapy, Image-Guided
1
2018
39
0.030
 Why?
Dose-Response Relationship, Drug
1
2002
2030
0.030
 Why?
Pregnancy
1
2011
7197
0.030
 Why?
Hyaluronic Acid
1
2020
225
0.030
 Why?
Fibrosis
1
2020
551
0.030
 Why?
Saccharomyces cerevisiae
1
2002
580
0.030
 Why?
Maytansine
1
2017
18
0.030
 Why?
rho Guanine Nucleotide Dissociation Inhibitor beta
1
2017
4
0.030
 Why?
Monocytes
1
2020
536
0.030
 Why?
Adaptor Proteins, Signal Transducing
1
2020
426
0.030
 Why?
Cyclin D1
1
2017
63
0.030
 Why?
DNA Mutational Analysis
1
2018
409
0.030
 Why?
Cell Cycle
2
2010
595
0.030
 Why?
Cyclin-Dependent Kinase 4
1
2017
53
0.030
 Why?
Cyclin-Dependent Kinase 6
1
2017
49
0.030
 Why?
Trastuzumab
1
2017
117
0.030
 Why?
DNA Repair
1
2019
256
0.030
 Why?
Time Factors
2
2010
7171
0.030
 Why?
RNA Interference
1
2018
473
0.030
 Why?
Tissue Array Analysis
1
2016
49
0.030
 Why?
Fibroblast Growth Factors
1
2017
188
0.030
 Why?
Bone Morphogenetic Protein Receptors
1
2015
5
0.030
 Why?
In Vitro Techniques
1
2017
1047
0.030
 Why?
Ligands
1
2017
667
0.030
 Why?
DNA Damage
1
2018
434
0.030
 Why?
Combined Modality Therapy
1
2018
1269
0.030
 Why?
Organ Culture Techniques
1
2015
149
0.030
 Why?
Muscle, Skeletal
1
2025
1794
0.030
 Why?
Spheroids, Cellular
1
2015
74
0.030
 Why?
c-Mer Tyrosine Kinase
1
2014
38
0.030
 Why?
Mechanistic Target of Rapamycin Complex 1
1
2015
138
0.030
 Why?
Biomarkers
2
2018
4283
0.030
 Why?
Coculture Techniques
1
2014
246
0.030
 Why?
Myeloid Cell Leukemia Sequence 1 Protein
1
2013
39
0.030
 Why?
Genes, myc
1
2013
51
0.030
 Why?
Neoplasm Invasiveness
1
2015
505
0.020
 Why?
Ki-67 Antigen
1
2013
117
0.020
 Why?
Cisplatin
1
2015
345
0.020
 Why?
Neoplasm, Residual
1
2013
143
0.020
 Why?
Gene Dosage
1
2013
148
0.020
 Why?
DNA Copy Number Variations
1
2013
184
0.020
 Why?
Phagocytosis
1
2014
297
0.020
 Why?
Drug Synergism
1
2013
353
0.020
 Why?
Receptor Protein-Tyrosine Kinases
1
2014
230
0.020
 Why?
Cluster Analysis
1
2013
517
0.020
 Why?
Epithelial-Mesenchymal Transition
1
2013
211
0.020
 Why?
Cell Line, Transformed
1
2011
138
0.020
 Why?
Oligonucleotide Array Sequence Analysis
1
2013
751
0.020
 Why?
Postpartum Period
1
2014
373
0.020
 Why?
Antibodies, Monoclonal, Humanized
1
2017
994
0.020
 Why?
Cell Growth Processes
1
2011
47
0.020
 Why?
Proto-Oncogene Proteins
1
2014
620
0.020
 Why?
Alkylation
1
2010
26
0.020
 Why?
Cyclin A
1
2010
17
0.020
 Why?
Treatment Outcome
2
2018
11831
0.020
 Why?
Oligonucleotides, Antisense
1
2011
118
0.020
 Why?
Neoadjuvant Therapy
1
2013
466
0.020
 Why?
Immunoenzyme Techniques
1
2010
199
0.020
 Why?
Survival Analysis
1
2013
1374
0.020
 Why?
Receptor, IGF Type 1
1
2010
63
0.020
 Why?
Caspases
1
2010
229
0.020
 Why?
Immunoprecipitation
1
2010
147
0.020
 Why?
Quality of Life
1
2022
3195
0.020
 Why?
Mitogen-Activated Protein Kinase 1
1
2010
171
0.020
 Why?
Proteasome Endopeptidase Complex
1
2010
153
0.020
 Why?
Reverse Transcriptase Polymerase Chain Reaction
1
2010
975
0.020
 Why?
Interleukin-6
1
2011
772
0.020
 Why?
Estrogens
1
2010
364
0.020
 Why?
Cytokines
1
2014
2054
0.020
 Why?
Mass Spectrometry
1
2010
744
0.020
 Why?
Recombinant Proteins
1
2010
1367
0.020
 Why?
Biological Transport
1
2007
422
0.010
 Why?
Adenocarcinoma
1
2012
923
0.010
 Why?
Cells, Cultured
1
2010
4127
0.010
 Why?
Aged
1
2018
26125
0.010
 Why?
Middle Aged
1
2018
36176
0.010
 Why?
Young's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (308) concept(s)
_
Co-Authors Expand Description
See all (30) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department
Physical Neighbors Expand Description
_

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)